Panacea Biotec Ltd.
|
Ratio Analysis
|
|
You can view the
Ratio Analysis
for the last 5 years.
Market Cap. (Rs.)
|
835.46 Cr.
|
P/BV
|
1.02
|
Book Value (Rs.)
|
134.19
|
52 Week High/Low (Rs.)
|
203/114
|
FV/ML
|
1/1
|
P/E(X)
|
0.00
|
Bookclosure
|
29/09/2023
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | |
PER SHARE RATIOS | | | | | |
| | | | | |
Basic EPS (Rs.) | -5.43 | 175.98 | -24.11 | -31.72 | 6.15 |
Diluted EPS (Rs.) | -5.43 | 175.98 | -24.11 | -31.72 | 6.15 |
Cash EPS (Rs.) | 0.87 | 183.11 | -16.68 | -24.72 | 14.94 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 133.63 | 138.09 | -41.36 | 28.40 | 55.14 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 133.63 | 138.09 | -41.36 | 28.40 | 55.14 |
Revenue From Operations / Share (Rs.) | 75.09 | 107.96 | 102.01 | 88.83 | 74.56 |
PBDIT / Share (Rs.) | -7.56 | -0.47 | 14.14 | 9.97 | -20.69 |
PBIT / Share (Rs.) | -13.95 | -7.60 | 6.70 | 2.91 | -29.50 |
PBT / Share (Rs.) | 2.09 | 236.54 | -23.56 | -28.01 | 7.91 |
Net Profit / Share (Rs.) | -5.51 | 175.98 | -24.12 | -31.78 | 6.13 |
NP After MI And SOA / Share (Rs.) | -5.43 | 175.98 | -24.11 | -31.72 | 6.16 |
| | | | | |
PROFITABILITY RATIOS | | | | | |
| | | | | |
PBDIT Margin (%) | -10.06 | -0.43 | 13.86 | 11.22 | -27.74 |
PBIT Margin (%) | -18.57 | -7.04 | 6.56 | 3.27 | -39.56 |
PBT Margin (%) | 2.78 | 219.10 | -23.09 | -31.53 | 10.61 |
Net Profit Margin (%) | -7.33 | 163.01 | -23.64 | -35.77 | 8.21 |
NP After MI And SOA Margin (%) | -7.22 | 163.01 | -23.63 | -35.70 | 8.26 |
Return on Networth / Equity (%) | -4.04 | 126.99 | 0.00 | -109.75 | 11.07 |
Return on Capital Employeed (%) | -9.09 | -4.75 | 5.44 | 1.90 | -41.32 |
Return On Assets (%) | -2.61 | 60.47 | -12.52 | -13.97 | 2.74 |
Long Term Debt / Equity (X) | 0.01 | 0.03 | -2.92 | 3.45 | 0.10 |
Total Debt / Equity (X) | 0.01 | 0.03 | -2.92 | 3.47 | 0.30 |
Asset Turnover Ratio (%) | 0.30 | 0.24 | 0.31 | 0.12 | 0.06 |
| | | | | |
LIQUIDITY RATIOS | | | | | |
| | | | | |
Current Ratio (X) | 1.71 | 1.30 | 1.20 | 1.50 | 0.54 |
Quick Ratio (X) | 1.10 | 1.03 | 0.79 | 1.18 | 0.45 |
Inventory Turnover Ratio (X) | 1.02 | 1.14 | 0.58 | 0.83 | 0.31 |
| | | | | |
COVERAGE RATIOS | | | | | |
| | | | | |
Interest Coverage Ratio (%) | -10.43 | -0.01 | 0.46 | 0.35 | -1.21 |
Interest Coverage Ratio (Post Tax) (%) | -29.74 | -2.31 | 0.21 | 0.01 | -1.80 |
| | | | | |
VALUATION RATIOS | | | | | |
| | | | | |
Enterprise Value (Cr.) | 454.38 | 355.93 | 1682.86 | 1194.59 | 1302.99 |
EV / Net Operating Revenue (X) | 0.98 | 0.53 | 2.69 | 2.20 | 2.85 |
EV / EBITDA (X) | -9.81 | -122.86 | 19.43 | 19.57 | -10.28 |
MarketCap / Net Operating Revenue (X) | 1.44 | 1.37 | 1.74 | 1.23 | 2.66 |
Price / BV (X) | 0.80 | 1.07 | -4.34 | 3.79 | 3.56 |
Price / Net Operating Revenue (X) | 1.44 | 1.37 | 1.74 | 1.23 | 2.66 |
EarningsYield | -0.05 | 1.19 | -0.13 | -0.28 | 0.03 |